Clinical Trials

Stomach Neoplasms

NCT06519591 2026-02-18

Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

40 enrolled

Stomach Neoplasms

NCT07194005 2025-09-26

Remission

Stomach Neoplasms

NCT07007182 2025-09-05

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

54 enrolled

Stomach Neoplasms

NCT07018063 2025-06-12

YOUNG-NEOS

35 enrolled

Neoplasms, Stomach Neoplasms

NCT06881017 2025-03-18

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

140 enrolled

Stomach Neoplasms

NCT04863430 2025-02-21

Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach

Phase 2 Withdrawn

Stomach Neoplasms

NCT06730373 2024-12-31

First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)

110 enrolled

Stomach Neoplasms

NCT03878472 2024-12-16

Neoadjuvant Immunotherapy for Resectable Gastric Cancer

25 enrolled

Stomach Neoplasms

NCT06487429 2024-07-05

Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer

28 enrolled

Stomach Neoplasms

NCT06454435 2024-06-12

Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer

158 enrolled

Stomach Neoplasms

NCT06451211 2024-06-11

Neo-ICEBOAT

53 enrolled

Stomach Neoplasms

NCT06447636 2024-06-07

Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Stomach Neoplasms

NCT06385873 2024-05-13

RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

32 enrolled

Stomach Neoplasms

NCT06341595 2024-04-02

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

40 enrolled

Stomach Neoplasms

NCT05184803 2024-02-28

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

63 enrolled

Stomach Neoplasms

NCT04694183 2024-02-07

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

37 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT06213519 2024-01-19

HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis

69 enrolled

Stomach Neoplasms

NCT04999332 2023-11-15

LOTS

58 enrolled

Stomach Neoplasms

NCT05948449 2023-07-17

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

37 enrolled

Stomach Neoplasms

NCT04267549 2023-07-06

Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer

47 enrolled

Stomach Neoplasms

NCT05853172 2023-05-10

Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer

Stomach Neoplasms

NCT05687357 2023-04-19

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

140 enrolled

Stomach Neoplasms

NCT05052931 2023-04-13

Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer

10 enrolled

Stomach Neoplasms

NCT05769725 2023-03-15

A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer

70 enrolled

Stomach Neoplasms

NCT02191566 2022-12-08

SOHUG

8 enrolled

Stomach Neoplasms

NCT05627414 2022-11-25

Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer

Stomach Neoplasms

NCT02725424 2022-08-17

MATCH

180 enrolled

Stomach Neoplasms

NCT04062058 2022-01-24

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

82 enrolled

Stomach Neoplasms

NCT05111444 2021-11-08

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

65 enrolled

Stomach Neoplasms

NCT02128243 2021-03-26

MATEO

242 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT04338438 2020-11-10

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

37 enrolled

Stomach Neoplasms

NCT04367025 2020-04-29

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

70 enrolled

Stomach Neoplasms

NCT04152889 2020-04-20

A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer

Stomach Neoplasms

NCT04258657 2020-02-06

Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer

Stomach Neoplasms

NCT02301481 2019-10-16

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

71 enrolled

Stomach Neoplasms

NCT03263741 2019-07-08

Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer

Stomach Neoplasms

NCT03990103 2019-06-19

S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

66 enrolled

Stomach Neoplasms

NCT02216149 2018-08-28

FluoHeart

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT03007446 2017-09-27

The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer

Stomach Neoplasms

NCT03271073 2017-09-01

A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

Stomach Neoplasms

NCT02527785 2017-08-23

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT02229058 2017-07-27

Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer

73 enrolled

Stomach Neoplasms

NCT02779608 2017-01-24

The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites

50 enrolled

Stomach Neoplasms

NCT02949258 2016-10-31

NCT-B4

40 enrolled

Stomach Neoplasms

NCT01946061 2016-08-19

A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer

3 enrolled

Stomach Neoplasms

NCT01980810 2016-06-14

GC-A-003

36 enrolled

Stomach Neoplasms

NCT02623153 2015-12-07

Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer

200 enrolled

Stomach Neoplasms

NCT02525237 2015-08-17

Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer

Stomach Neoplasms

NCT01679340 2015-05-19

A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery

160 enrolled